Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.

@article{Colomo2003ClinicalIO,
  title={Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma.},
  author={Llu{\'i}s Colomo and Armando L{\'o}pez-Guillermo and Mar{\'i}a Jos{\'e} Navarro Perales and Susana Rives and Antonio Mart{\'i}nez and Francesc Bosch and Dolors Colomer and Brunangelo Falini and Emili Montserrat and El{\'i}as Campo},
  journal={Blood},
  year={2003},
  volume={101 1},
  pages={
          78-84
        }
}
To analyze the relationship between immunophenotyping profile and main clinicopathological features and outcome in diffuse large B-cell lymphoma (DLBCL), we studied 128 patients (59 men, 69 women; median age 65 years) consecutively diagnosed with de novo DLBCL in a single institution. Cells from each patient were immunostained with CD20, CD79a, CD5, CD10, bcl-6, MUM1, CD138, bcl-2, p53, p27, and Ki-67 antibodies. Four immunophenotyping profiles were distinguished according to the pattern of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 194 CITATIONS, ESTIMATED 48% COVERAGE

Lymphomas of the head and neck region: an update

  • Virchows Archiv
  • 2019
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma

  • Turkish journal of haematology : official journal of Turkish Society of Haematology
  • 2013
VIEW 7 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2004
2019

CITATION STATISTICS

  • 17 Highly Influenced Citations

  • Averaged 7 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 46 REFERENCES